FERNANDO SILES: Open Payments
NPI 1851323059 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 16 payments from 5 companies in 2025. Trend: 2023 $744 · 2024 $216 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $413 |
| Axsome Therapeutics, Inc. | 2 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| ABBVIE INC. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: COBENFY, Auvelity, CAPLYTA, VRAYLAR, FANAPT.
Industry payments across TX — which companies pay providers there.
